Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
265 hedge funds and large institutions have $3.77B invested in Amedisys in 2018 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 85 increasing their positions, 87 reducing their positions, and 16 closing their positions.
319% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 16
45% more capital invested
Capital invested by funds: $2.6B → $3.77B (+$1.17B)
23% more funds holding
Funds holding: 216 → 265 (+49)
5.37% more ownership
Funds ownership: 89.48% → 94.85% (+5.4%)
2% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 87
29% less call options, than puts
Call options by funds: $12.3M | Put options by funds: $17.4M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$46.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.8M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$26.2M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$25.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$24.2M |
Top Sellers
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$90.9M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$44.6M |
| 3 |
BlackRock
New York
|
-$43M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$31.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$23.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FRM
276
Fox Run Management
Greenwich,
Connecticut
| – | -$214K | -2,506 | Closed |
|
|
PGA
277
Premia Global Advisors
Coral Gables,
Florida
| – | -$47K | -553 | Closed |
|
|
CF
278
Centaurus Financial
Anaheim,
California
| – | -$4K | -52 | Closed |
|
279
Envestnet Asset Management
Chicago,
Illinois
| – | -$3K | -39 | Closed |
|
AMED Hedge Fund Activity: Q3 2018 in Review
265 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2018, worth a combined $3.77B — up 45% from $2.6B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new AMED positions and 16 closed out — a net gain of 51 holders — while 85 added to existing stakes and 87 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $46.2M. The largest seller was American Century Companies, cutting an estimated $90.9M.
- 265 institutional investors held Amedisys (AMED) as of Q3 2018, up from 216 in Q2 2018.
- Funds reported $3.77B of Amedisys stock for Q3 2018, up 45% quarter-over-quarter.
- 67 funds opened new Amedisys positions in Q3 2018 and 16 closed out, a net change of +51 holders.
- The largest Amedisys buyer in Q3 2018 was Acadian Asset Management, an estimated $46.2M added.
- The largest Amedisys seller in Q3 2018 was American Century Companies, an estimated $90.9M sold.
Based on aggregated 13F filings for Q3 2018.